TG THERAPEUTICS, INC.: cash_and_restricted_cash
| Value | {"amount": 483939000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df0c76f6-c20c-43f1-bb60-e1b2c2238637
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-26-025955Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cash-and-restricted-cash/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df0c76f6-c20c-43f1-bb60-e1b2c2238637
History
- no predecessors — first report